Cabrini Health

Malvern, Victoria 3144

2 studies enrolling now · 8 studies all time

What they study most

Antimicrobial, Bacteremia, Breast Cancer, Cardiovascular Diseases, Critically Ill, Diabetes Mellitus, Type 2, Disorder; Heart, Functional, Postoperative, Cardiac Surgery, Endometrial Cancer, Hypertension, Intensive Care, Lymphoma, Lymphoma, Non Hodgkin

Studies at this site

• EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease — Recruiting now
• TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas — Recruiting now
• Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma — Running, not enrolling
• Pembrolizumab (MK-3475) Plus Epacadostat vs Standard of Care in mRCC (KEYNOTE-679/ECHO-302) — Completed
• Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC) — Completed
• Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness — Completed
• Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients — Stopped early
• Transfusion Requirements in Cardiac Surgery III — Completed